Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXYM2K
|
||||
| Drug Name |
[(S)-1-((S)-1-Benzyl-2-phenylamino-ethylcarbamoyl)-3-methyl-butyl]-carbamic acid benzyl ester
|
||||
| Synonyms |
CHEMBL423447
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C29H35N3O3
|
||||
| Canonical SMILES |
CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@H](CNc2ccccc2)Cc3ccccc3
|
||||
| InChI |
InChI=1S/C29H35N3O3/c1-22(2)18-27(32-29(34)35-21-24-14-8-4-9-15-24)28(33)31-26(19-23-12-6-3-7-13-23)20-30-25-16-10-5-11-17-25/h3-17,22,26-27,30H,18-21H2,1-2H3,(H,31,33)(H,32,34)/t26-,27-/m0/s1
|
||||
| InChIKey |
FCHHEPKIESGJIH-SVBPBHIXSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.